Evidence map›Paper›PMID 30128007›Full record

ArticleOncology letters2018

Identification of a novel breast cancer-causing mutation in the

Yanyan Wang, Da Jiang, Qiang Zhao, Hui Huang, Xue Zhang, Yanzhi Cui, Jiayin Liu, Jing Wu, Keke Lin, Weixi Chen and 4 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. A NovelBreast cancer : basic and clinical research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Yanyan WangBGI Genomics, BGI-Shenzhen, Shenzhen, Guangdong 518083, P.R. China.
Da JiangDepartment of Internal Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.
Qiang ZhaoDepartment of Obstetrics and Gynecology, Jiangmen Central Hospital, Affiliated Jiangmen Hospital of Sun Yat-Sen University, Jiangmen, Guangdong 529030, P.R. China.
Hui HuangBGI Genomics, BGI-Shenzhen, Shenzhen, Guangdong 518083, P.R. China.
Xue ZhangDepartment of Internal Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.
Yanzhi CuiDepartment of Internal Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.
Jiayin LiuDepartment of Internal Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.
Jing WuBGI Genomics, BGI-Shenzhen, Shenzhen, Guangdong 518083, P.R. China.
Keke LinBGI Genomics, BGI-Shenzhen, Shenzhen, Guangdong 518083, P.R. China.
Weixi ChenBGI Genomics, BGI-Shenzhen, Shenzhen, Guangdong 518083, P.R. China.
Jiale XiangBGI Genomics, BGI-Shenzhen, Shenzhen, Guangdong 518083, P.R. China.
Hui JinDepartment of Internal Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.
Zhiyu PengBGI Genomics, BGI-Shenzhen, Shenzhen, Guangdong 518083, P.R. China.
Santasree BanerjeeBGI Genomics, BGI-Shenzhen, Shenzhen, Guangdong 518083, P.R. China.
BGI GenomicsBGI Group (China) · CNHebei Medical University · CNFourth Hospital of Hebei Medical University · CNJiangmen Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary breast cancer is an autosomal dominant syndrome caused by germ-line mutations in the human breast cancer genes,

Indexed as

deletionhereditary breast cancerheterozygousnovel mutationtargeted next generation sequencing

Identifiers

PMID30128007
PMCPMC6096242
OpenAlexW2845196341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.